메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Angel Chao (Chang Gung Memorial Hospital Linkou Medical Center) Yi-Hao Lin (Chang Gung Memorial Hospital Linkou Medical Center and Chang Gung University) Lan-Yan Yang (Chang Gung Memorial Hospital) Ren-Chin Wu (Chang Gung Memorial Hospital) Wei-Yang Chang (Clinical Trial Center Chang Gung Memorial Hospital) Pi-Yueh Chang (Department of Laboratory Medicine Chang Gung Memorial Hospital) Shih-Cheng Chang (Department of Laboratory Medicine Chang Gung Memorial Hospital) Chiao-Yun Lin (Gynecologic Cancer Research Center Chang Gung Memorial Hospital) Huei-Jean Huang (Department of Obstetrics and Gynecology Chang Gung Memorial Hospital) Cheng-Tao Lin (Department of Obstetrics and Gynecology Chang Gung Memorial Hospital) Hung-Hsueh Chou (Chang Gung University) Kuan-Gen Huang (Chang Gung Memorial Hospital at Linkou) Wen-Ling Kuo (Department of General Surgery Chang Gung Memorial Hospital Linkou Medical Center) Ting-Chang Chang (Chang Gung Memorial Hospital Linkou Medical Center and Chang Gung University) Chyong-Huey Lai (Chang Gung Memorial Hospital Linkou Branch)
저널정보
대한부인종양학회 Journal of Gynecologic Oncology Journal of Gynecologic Oncology Vol.31 No.3
발행연도
2020.1
수록면
1 - 12 (12page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Objective: The characteristics of patients with metachronous breast and ovarian malignancies and the pathogenic role of BRCA1/2 mutations remain poorly understood. We investigated these issues through a review of hospital records and nationwide Taiwanese registry data, followed by BRCA1/2 mutation analysis in hospital-based cases. Methods: We retrospectively retrieved consecutive clinical records of Taiwanese patients who presented with these malignancies to our hospital between 2001 and 2017. We also collected information from the Data Science Center of the Taiwan Cancer Registry (TCR) between 2007 and 2015. Next-generation sequencing and multiplex ligation-dependent probe amplification were used to identify BRCA1/2 mutations and large genomic rearrangements, respectively. When BRCA1/2 mutations were identified in index cases, pedigrees were reconstructed and genetic testing was offered to family members. Results: A total of 12,769 patients with breast cancer and 1,537 with ovarian cancer were retrieved from our hospital records. Of them, 28 had metachronous breast and ovarian malignancies. We also identified 113 cases from the TCR dataset. Eighteen hospital-based cases underwent BRCA1/2 sequencing and germline pathogenic mutations were detected in 7 patients (38.9%, 5 in BRCA1 and 2 in BRCA2). All BRCA1/2 mutation carriers had ovarian high-grade serous carcinomas. Of the 12 patients who were alive at the time of analysis, 5 were BRCA1/2 mutation carriers. All of them had family members with BRCA1/2-associated malignancies. Conclusions: Our results provide pilot evidence that BRCA1/2 mutations are common in Taiwanese patients with metachronous breast and ovarian malignancies, supporting the clinical utility of genetic counseling.

목차

등록된 정보가 없습니다.

참고문헌 (31)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0